Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. 1980

S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann

Double-stranded cDNA prepared from the 12S fraction of poly(A) RNA from interferon (IF)-producing human leukocytes was cloned in Escherichia coli using the pBR322 vector. One of the resulting clones had a 910-base pair insert which could hybridise to IF mRNA and was responsible for the production of a polypeptide with biological IF activity. Up to 10,000 units IF activity per g of cells was obtained from some clones.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014170 Transformation, Genetic Change brought about to an organisms genetic composition by unidirectional transfer (TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell's genome. Genetic Transformation,Genetic Transformations,Transformations, Genetic

Related Publications

S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
March 1983, Archives of biochemistry and biophysics,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
October 1980, Nature,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
September 1980, Nucleic acids research,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
January 1985, Revista latinoamericana de microbiologia,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
November 1962, Proceedings of the National Academy of Sciences of the United States of America,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
February 1981, Nucleic acids research,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
August 1981, Nature,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
May 1962, Biochemical and biophysical research communications,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
January 1982, Cancer chemotherapy and pharmacology,
S Nagata, and H Taira, and A Hall, and L Johnsrud, and M Streuli, and J Ecsödi, and W Boll, and K Cantell, and C Weissmann
January 1986, Archivum immunologiae et therapiae experimentalis,
Copied contents to your clipboard!